JD

Discussion in 'Merz Pharmaceuticals' started by Anonymous, Aug 1, 2014 at 7:02 PM.

Tags: Add Tags
  1. Anonymous

    Anonymous Guest

    Now you have sales veteran that understands the mechanics of the market. He may be a little on the used car side but he'll get the job done if the higher ups take his advice. Consider yourselves lucky and be ready to perform.
     

  2. Anonymous

    Anonymous Guest

    Yes, watch JD pull a rabbit out of his ass. What a clown. You kiss ass go back to your hole. This division is sinking and you can't pull through referrals without scientic accepted indications.

    What's the new indication? Pipeline?

    Why would a doctor "buy and bill" Botox vs Xeomin? The physician does not have to worry about being reimbursed as much as they do with Xeomin!

    Total Failure from day one- Clinically, Marketing, Payer Strategy, Pricing, and the clowns that drive this terd!
     
  3. Anonymous

    Anonymous Guest

    Sounds like it's time for you to move on.
     
  4. Anonymous

    Anonymous Guest

    How many indications does Xeomin have? I guess we should just promote to cash patients. Hell, I don't care if you were in Presidents Club for Veteran Used Car Salesman of the decade! You cannot sell an inferior product without reimbursement, managed care, and only 2 FDA approved indications. Obviously, you do not understand basic PHARMA Economics..
     
  5. Anonymous

    Anonymous Guest

    Better than Knock Knock Davey!